ANEBULO PHARMACEUTICALS INC (ANEB)
US0345691036 - Common Stock
| TTM (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -10.49M | -11.73M | -6.83M | -30.25M | -170.00K | |||
| Change In Working Capital | -4.24K | 1.16M | 910.00K | -1.45M | 20.00K | |||
| Interest Paid | N/A | N/A | 0.00 | 10.00K | N/A | |||
| Other non cash items | 901.90K | 880.00K | 480.00K | 26.83M | 0.00 | |||
| OPERATING CASH FLOW | -9.58M | -9.68M | -5.44M | -4.87M | -150.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -200.00K | 200.00K | |||
| Stock Issued/Repurchased | 0.00 | 6.70M | 0.00 | 22.85M | 3.00M | |||
| Other Financing Activity | N/A | -320.00K | 0.00 | -820.00K | -20.00K | |||
| FINANCING CASH FLOW | -132.35K | 6.38M | 0.00 | 21.83M | 3.18M | |||
| CHANGE IN CASH | -9.71M | -3.30M | -5.44M | 16.96M | 3.02M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.58M | -9.68M | -5.44M | -4.87M | -150.00K | |||
| FREE CASH FLOW | -9.58M | -9.68M | -5.44M | -4.87M | -150.00K | |||
All data in USD